EUCTR2004-002686-21-AT进行中（未招募）1 期
Efficacy of Endothelin 1 receptor antagonist Bosentan in secondary Raynauds Syndrom - Bosentan1
Dept of Dermatology0 个研究点目标入组 40 人开始时间: 2005年1月18日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •adult patients with secondary Raynauds syndrome
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •primary Raynuads syndrome
- •pulmonal hypertension WHO III IV
- •parenteral prostanoids
- •Treatment of PDE with Sildenafil
- •pregnancy, breast feeding
- •pretreatment with bosentan
- •AST or ALT > §ULN
研究者
相似试验
进行中（未招募）
1 期
Efficacy of endothelin receptor antagonism in treatment of coronary artery spasm: a randomized controlled clinical trial. (EDIT-CAS)CTIS2023-507782-25-00Stichting Radboud University Medical Center100
进行中（未招募）
不适用
Effects of non-specific Endothelin-A receptor blockade on ocular blood flow in patients with glaucomapatients with primary open angle glaucoma in comparision to a healthy control group.EUCTR2006-003140-27-ATDepartment of Clinical Pharmacology28
进行中（未招募）
1 期
se of endothelin-1 antagonists in patients with Established Pulmonary Hypertension and Fibrotic Lung Disease. – A randomised, placebo-controlled, double-blinded study. - Tracleer in Interstitial Lung Disease and Pulmonary HypertensioPulmonary hypertension in patients with interstitial lung disease.MedDRA version: 9.1 Level: LLT Classification code 10064911 Term: Pulmonary arterial hypertensionEUCTR2007-001643-21-GBRoyal Brompton and Harefield NHS Trust48
招募中
2 期
A Study to Assess the Effects of the Endothelin Receptor Antagonist Zibotentan and the SGLT2 Inhibitor Dapagliflozin in Patients elevated Albuminuria: a Randomized Double Blind Cross-Over Trialdiabetic kidney disease1001265310029149diabetic nephropathyNL-OMON54022niversitair Medisch Centrum Groningen12
进行中（未招募）
1 期
A Study to Assess the Effects of the drugs Zibotentan and Dapagliflozin in Patients with Elevated Levels of Protein in UrinePatients with elevated AlbuminuriaMedDRA version: 21.1Level: PTClassification code 10061835Term: Diabetic nephropathySystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 20.0Level: PTClassification code 10016807Term: Fluid retentionSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: PTClassification code 10001580Term: AlbuminuriaSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2021-001324-18-NLniversity Medical Center Groningen38